Behavioral Interventions for Improvement of Adherence at Exercise-based Cardiac Rehabilitation (ECRA) (ECRA)

October 15, 2021 updated by: Maria Bäck, Linkoeping University
The purpose of this study is to investigate the effects of an extended behavioral intervention in exercise-based CR for improvement of physical capacity, adherence, psychological and physiological parameters, compared with usual care.

Study Overview

Status

Completed

Detailed Description

Consecutive patients will be included at the coronary care unit (CCU), Linköping University Hospital, Sweden. Physiotherapists ask patients for informed consent at the CCU and book an appointment at the exercise-based CR 2-3 weeks after discharge for baseline tests. After baseline testing patients will be randomized to either extended intervention or routine care. Randomization will be stratified by submaximal exercise capacity. Patients randomized to the extended intervention group receive an additional appointment to a physiotherapist within a week. Thereafter patients in both groups start the exercise-based CR program, including aerobic exercise and resistance exercise, 3 times/week for 16 weeks, according to international guidelines for exercise-based CR.

The extended intervention is based on components from behavioral medicine including: specific goal-setting, self-monitoring and feed-back.

Changes in the endpoint variables will be measured from baseline to first (16 weeks at end of intervention) and second (12 months after index event) follow-up visits.

Sample size calculations are based on previous clinical data from a similar exercise-based CR setting (n=50) on differences in aerobic exercise capacity measured by submaximal exercise test (watts) before vs after finished exercise-based CR. With a power of 80% and a two-sided significance level of p<0.05 and least mean difference at 10 watts (SD 20 watts) and a calculated loss of follow-up of 20%, the estimated sample size is 160 patients.

Study Type

Interventional

Enrollment (Actual)

170

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Linkoeping, Sweden, 58183
        • Linkoeping University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Primary care event due to coronary artery disease and/or percutaneous coronary intervention (PCI) at the coronary care unit, Linköping University hospital
  • Age <75 years

Exclusion Criteria:

  • Serious physical or psychological disease interfering with participation in exercise-based CR
  • Inability to understand the Swedish language

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Extended behavioral intervention
Specific goal-setting, self-monitoring and feed-back
The exercise goal is set in liaison between the patient and the physiotherapist, based on activities and target behaviors that the patient thinks is relevant and important. The patients are asked to self-monitor the defined exercise goal by completing an exercise diary. The exercise diary includes specification of the performed exercise dose (frequency, intensity and duration). The exercise diary is followed up by a physiotherapist every third week by a phone call or a personal meeting. Visual feed-back on the performed dose of exercise is given once by accelerometry. At end of intervention (16 weeks) the patient is offered a follow-up meeting with the physiotherapist to discuss a long-term exercise goal.
No Intervention: Usual care
Hospital-based or home-based aerobic exercise 3 times a week with a duration of 30-60 minutes and an intensity of 40-80 % of Vo2max and resistance exercise 2 times a week of 1-3 sets of 10-15 repetitions. The exercise period is 16 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline aerobic exercise capacity (watts) at 4 months
Time Frame: 4 months
The test is performed on a bicycle ergometer according to the WHO-protocol with an increased workload of 25W every 4.5 minutes.The exercise test is discontinued at Borg RPE 17 and/or dyspnea 7 at Borg´s CR-10 scale.
4 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adherence to dose of exercise
Time Frame: 4 months
accelerometer
4 months
Adherence to dose in exercise
Time Frame: 4 months
exercise diary
4 months
Change from baseline unilateral isotonic shoulder flexion (repetitions) at 4 months
Time Frame: 4 months
Muscle endurance test
4 months
Change from baseline unilateral isotonic heel lift (repetitions) at 4 months
Time Frame: 4 months
Muscle endurance test
4 months
Change from baseline anxiety score at 4 months
Time Frame: 4 months
Hospital Anxiety and Depression Scale (HADS)
4 months
Change from baseline depression score at 4 months
Time Frame: 4 months
Hospital Anxiety and Depression Scale (HADS)
4 months
Change from baseline self-efficacy score at 4 months
Time Frame: 4 months
Self Efficacy Exercise Scale (SEE-SV)
4 months
Change from baseline health-related quality of life score at 4 months
Time Frame: 4 months
Short-Form-36 (SF-36)
4 months
Change from baseline health-related quality of life score at 4 months
Time Frame: 4 months
EQ5D
4 months
Change from baseline level of physical activity at 4 months
Time Frame: 4 months
Accelerometer
4 months
Change from baseline level of physical activity at 4 months
Time Frame: 4 months
Bouchard questionnaire
4 months
Change from baseline aerobic exercise capacity (watts) at 12 months
Time Frame: 12 months
Submaximal exercise test on bicycle ergometer
12 months
Adherence to dose of exercise
Time Frame: 12 months
Accelerometer
12 months
Adherence to dose of exercise
Time Frame: 12 months
Exercise diary
12 months
Change from baseline unilateral isotonic shoulder flexion (repetitions) at 12 months
Time Frame: 12 months
Muscle endurance test
12 months
Change from baseline unilateral isotonic heel lift (repetitions) at 12 months
Time Frame: 12 months
Muscle endurance test
12 months
Change from baseline anxiety score at 12 months
Time Frame: 12 months
Hospital Anxiety and Depression Scale (HADS)
12 months
Change from baseline depression score at 12 months
Time Frame: 12 months
Hospital Anxiety and Depression Scale (HADS)
12 months
Change from baseline self-efficacy score at 12 months
Time Frame: 12 months
Self Efficacy Exercise Scale (SEE-SV)
12 months
Change from baseline health-related quality of life score at 12 months
Time Frame: 12 months
Short-Form-36 (SF-36)
12 months
Change from baseline health-related quality of life score at 12 months
Time Frame: 2 months
EQ5D
2 months
Change from baseline level of physical activity at 12 months
Time Frame: 12 months
accelerometer
12 months
Change from baseline level of physical activity at 12 months
Time Frame: 12 months
Bouchard questionnaire
12 months
Patient Enablement (score)
Time Frame: 12 months
Patient Enablement Instrument (PEI)
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Maria Bäck, PhD, Linkoeping University, Department of Medical and Health Sciences, Division of Physiotherapy

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 15, 2016

Primary Completion (Actual)

April 15, 2019

Study Completion (Actual)

June 1, 2021

Study Registration Dates

First Submitted

August 16, 2016

First Submitted That Met QC Criteria

September 5, 2016

First Posted (Estimate)

September 9, 2016

Study Record Updates

Last Update Posted (Actual)

October 18, 2021

Last Update Submitted That Met QC Criteria

October 15, 2021

Last Verified

October 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Coronary Artery Disease

Clinical Trials on Extended behavioral intervention

Subscribe